Oncolix's Debt - II Round

Oncolix raised a round of funding on February 06, 2017.

Oncolix is a clinical-stage bio-pharmaceutical company developing Prolanta, a targeted therapeutic protein for the treatment of ovarian and breast cancer. The aim of Oncolix's product development is t…

Articles about Oncolix's Debt - II Round: